Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

Join AgBio+AgTech at the First Flight Venture Center for a conversation with Dr. Sharon Inch, plant pathologist and innovator behind Soil Sync and AgVision Analytics. Dr. Inch will share how she ...

Join Innovate Carolina on December 4 for an evening celebrating innovation, invention, and the journey from academic discovery to real-world impact.

Tract Bio, a Boston-based biotechnology company developing novel therapies for cancer and inflammatory diseases, has opened a new research laboratory in Charlotte with plans to grow. The 4,000 ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, said it was recently approved by Novant Health as a designated vendor for URO-1’s SUREcore and coreCARE ...

Novartis Gene Therapies, a division of Switzerland-based Novartis, one of the world’s largest pharmaceutical companies, plans to expand in the Research Triangle with $771 million of investments at ...